00000nam 2200000zi 4500 9.923285 CaOODSP 20230907131433 m o d f cr mn||||||||| 230529e20230609onc ob f000 0 eng d 9780660489308 (statement) 9780660489315 (summary) CaOODSP eng rda CaOODSP n-cn--- HP5-158/1-2023E-PDF HP5-158/2-2023E-PDF Interim guidance on the use of bivalent Omicron-containing COVID-19 vaccines for primary series. Guidance on bivalent Omicron-containing COVID-19 vaccines for primary series Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, 2023. ©2023 1 online resource (19 pages) + summary (4 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Directives provisoires sur l'utilisation de vaccins bivalents contre la COVID-19 contenant Omicron dans le cadre d'une série primaire. Cover title. On cover: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). "Pub.: 230092"--Verso of cover. "Pub.: 230094"--Verso of cover (summary). Includes bibliographical references (pages 15-19). COVID-19 vaccines Canada. COVID-19 (Disease) Vaccination Canada. COVID-19 vaccines Government policy Canada. COVID-19 (Disease) Vaccination Government policy Canada. Canada. National Advisory Committee on Immunization, issuing body. Directives provisoires sur l'utilisation de vaccins bivalents contre la COVID-19 contenant Omicron dans le cadre d'une série primaire. (CaOODSP)9.923287 PDF 638 KB https://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-158-1-2023-eng.pdf (statement) PDF 415 KB https://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-158-2-2023-eng.pdf (summary) HTML N/A https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-interim-guidance-use-bivalent-omicron-containing-covid-19-vaccines-primary-series.html (statement) HTML N/A https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-interim-guidance-use-bivalent-omicron-containing-covid-19-vaccines-primary-series.html (summary) 230092 230094